グルコースモニタリングデバイス市場：タイプ、用途、エンドユーザー別-2025年～2030年の世界予測

グルコースモニタリングデバイス市場は、2023年に73億7,000万米ドルと評価され、2024年には82億6,000万米ドルに達すると予測され、CAGR 12.43％で成長し、2030年には167億5,000万米ドルに達すると予測されています。

グルコースモニタリングデバイスには、糖尿病の管理に不可欠な血糖値を測定し、リアルタイムでフィードバックするツールが含まれます。これらの機器の必要性は、世界の糖尿病罹患率の上昇、健康意識の高まり、ヘルスケア技術の進歩によってもたらされています。その用途は、持続グルコースモニター（CGM）、フラッシュグルコースモニター、従来の自己血糖測定（SMBG）機器に及び、主に糖尿病患者、病院、診療所で使用されています。最終用途の範囲には、個人使用、病院治療、外来設定が含まれます。主な成長要因としては、糖尿病の遠隔モニタリングおよび管理ソリューションに対する需要の高まり、非侵襲的・低侵襲的モニタリング技術などの技術進歩、ヘルスケア支出の増加などが挙げられます。潜在的なビジネスチャンスとしては、予測分析のための人工知能と機械学習の統合、スマートフォンアプリのインターフェースによるユーザーエクスペリエンスの向上、糖尿病有病率が上昇している新興市場への進出などが挙げられます。こうした機会を活用するために、企業は精度と信頼性を向上させたユーザーフレンドリーな機器の開発と、新興地域における販売網の拡大に注力すべきです。しかし、市場は厳しい規制要件、高度な機器の高コスト、データのプライバシーや取り扱いに関する問題などの課題に直面しており、これが普及率を鈍らせる要因となっています。植え込み型センサー、インスリンポンプとモニターを統合したクローズドループシステム、継続的モニタリングのためのウェアラブル技術の使用といった分野での革新が期待されます。市場は急速な技術進歩によってダイナミックに変化しており、使いやすさと手頃な価格という課題に対処できるイノベーターには、差別化と成長の大きな余地があります。事業成長のためには、企業はセンサーの精度向上、使いやすさを追求した製品設計の強化、世界の健康・安全基準への準拠のための調査を優先し、この高い可能性と進化を遂げる市場で競争優位に立つべきです。

市場力学：急速に進化するグルコースモニタリングデバイス市場の主要市場インサイトを公開

グルコースモニタリングデバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

• 市場促進要因
  • 世界の慢性疾患患者の増加
  • グルコースモニタリングデバイスに対する規制当局の承認急増
  • 在宅治療とセルフメディケーションのニーズの高まり
• 市場抑制要因
  • 不利な償還政策
• 市場機会
  • 技術の進歩と過剰な研究開発
  • 非侵襲的方法への嗜好の高まり
• 市場の課題
  • 標準化の欠如

ポーターの5つの力：グルコースモニタリングデバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：グルコースモニタリングデバイス市場における外部からの影響の把握

外部マクロ環境要因は、グルコースモニタリングデバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析グルコースモニタリングデバイス市場における競合情勢の把握

グルコースモニタリングデバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスグルコースモニタリングデバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、グルコースモニタリングデバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨グルコースモニタリングデバイス市場における成功への道筋を描く

グルコースモニタリングデバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患の症例が増加
    • グルコースモニタリングデバイスの規制承認が急増
    • 在宅治療と自己投薬の必要性が高まる
  • 抑制要因
    • 不利な払い戻しポリシー
  • 機会
    • 技術の進歩と過剰な研究開発
    • 非侵襲的治療法への好感度の高まり
  • 課題
    • 標準化の欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 グルコースモニタリングデバイス市場：タイプ別

• 糖尿病モニタリングデバイス
  • 継続的グルコースモニタリングデバイス
  • グルコースメーター
  • グルコーステストストリップ
  • ランセットと穿刺器具
• インスリン投与装置
  • インスリンペン
  • インスリンポンプ
  • インスリン注射器

第7章 グルコースモニタリングデバイス市場：用途別

• 妊娠糖尿病
• 1型糖尿病
• 2型糖尿病

第8章 グルコースモニタリングデバイス市場：エンドユーザー別

• 診断
• ホーム設定
• 病院

第9章 南北アメリカのグルコースモニタリングデバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のグルコースモニタリングデバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのグルコースモニタリングデバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AstraZeneca Plc
• B. Braun Melsungen AG
• Bayer AG
• Becton, Dickinson & Company
• DexCom, Inc.
• GE Healthcare
• GlaxoSmithKline PLC
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Lupin Limited
• Medtronic, Plc
• Merck & Co., Inc.
• Nova Biomedical Corporation
• Novartis AG
• Omron Corporation
• ResMed Inc.

LIST OF FIGURES

• FIGURE 1. GLUCOSE MONITORING DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. GLUCOSE MONITORING DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. GLUCOSE MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GLUCOSE MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GLUCOSE MONITORING DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS & LANCING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 46. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 72. CHINA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 73. CHINA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. CHINA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. INDIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 78. INDIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. INDIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. ITALY GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. ITALY GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. ITALY GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 183. POLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. POLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. POLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. QATAR GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 189. QATAR GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. QATAR GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 237. GLUCOSE MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Glucose Monitoring Devices Market was valued at USD 7.37 billion in 2023, expected to reach USD 8.26 billion in 2024, and is projected to grow at a CAGR of 12.43%, to USD 16.75 billion by 2030.

Glucose Monitoring Devices encompass tools that measure and provide real-time feedback on blood glucose levels, critical for managing diabetes. The necessity for these devices is driven by the rising incidence of diabetes globally, increased health awareness, and advancements in healthcare technology. Their application spans across continuous glucose monitors (CGMs), flash glucose monitors, and traditional self-monitoring blood glucose (SMBG) devices, primarily used by individuals with diabetes, hospitals, and clinics. The end-use scope includes personal use, hospital care, and ambulatory settings. Key growth influencers include the growing demand for remote diabetes monitoring and management solutions, technological advancements such as non-invasive and minimally invasive monitoring techniques, and increased healthcare spending. Potential opportunities involve the integration of artificial intelligence and machine learning for predictive analytics, enhancing user experience through smartphone app interfaces, and expanding into emerging markets where diabetes prevalence is rising. To capitalize on these opportunities, companies should focus on developing user-friendly devices with improved accuracy and reliability and expanding their distribution networks in developing regions. However, the market faces challenges such as stringent regulatory requirements, the high cost of advanced devices, and issues related to data privacy and handling, which can slow down adoption rates. Innovations are expected in areas like implantable sensors, closed-loop systems integrating insulin pumps with monitors, and the use of wearable technology for continuous monitoring. The market is dynamic with rapid technological advancements, offering significant scope for differentiation and growth to innovators who can address usability and affordability challenges. For business growth, companies should prioritize research into improving sensor accuracy, enhancing product design for ease of use, and ensuring compliance with global health and safety standards to gain a competitive edge in this highly potential and evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glucose Monitoring Devices Market

The Glucose Monitoring Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising cases of chronic disease across the globe
  • Surging regulatory approvals for glucose monitoring devices
  • Increasing need for home-based treatment and self-medication
• Market Restraints
  • Unfavorable reimbursement policies
• Market Opportunities
  • Technological advancements and excessive research & development
  • Rising preference for non-invasive methods
• Market Challenges
  • Lack of standardization

Porter's Five Forces: A Strategic Tool for Navigating the Glucose Monitoring Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glucose Monitoring Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glucose Monitoring Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glucose Monitoring Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glucose Monitoring Devices Market

A detailed market share analysis in the Glucose Monitoring Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glucose Monitoring Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glucose Monitoring Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glucose Monitoring Devices Market

A strategic analysis of the Glucose Monitoring Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glucose Monitoring Devices Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca Plc, B. Braun Melsungen AG, Bayer AG, Becton, Dickinson & Company, DexCom, Inc., GE Healthcare, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lupin Limited, Medtronic, Plc, Merck & Co., Inc., Nova Biomedical Corporation, Novartis AG, Omron Corporation, and ResMed Inc..

Market Segmentation & Coverage

This research report categorizes the Glucose Monitoring Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Diabetes Monitoring Devices and Insulin Delivery Devices. The Diabetes Monitoring Devices is further studied across Continuous Glucose Monitoring Devices, Glucose Meter, Glucose Test Strips, and Lancets & Lancing Devices. The Insulin Delivery Devices is further studied across Insulin Pens, Insulin Pumps, and Insulin Syringes.
• Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
• Based on End-User, market is studied across Diagnostics, Home Settings, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising cases of chronic disease across the globe
    • 5.1.1.2. Surging regulatory approvals for glucose monitoring devices
    • 5.1.1.3. Increasing need for home-based treatment and self-medication
  • 5.1.2. Restraints
    • 5.1.2.1. Unfavorable reimbursement policies
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and excessive research & development
    • 5.1.3.2. Rising preference for non-invasive methods
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standardization
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Glucose Monitoring Devices Market, by Type

• 6.1. Introduction
• 6.2. Diabetes Monitoring Devices
  • 6.2.1. Continuous Glucose Monitoring Devices
  • 6.2.2. Glucose Meter
  • 6.2.3. Glucose Test Strips
  • 6.2.4. Lancets & Lancing Devices
• 6.3. Insulin Delivery Devices
  • 6.3.1. Insulin Pens
  • 6.3.2. Insulin Pumps
  • 6.3.3. Insulin Syringes

7. Glucose Monitoring Devices Market, by Application

• 7.1. Introduction
• 7.2. Gestational Diabetes
• 7.3. Type 1 Diabetes
• 7.4. Type 2 Diabetes

8. Glucose Monitoring Devices Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostics
• 8.3. Home Settings
• 8.4. Hospitals

9. Americas Glucose Monitoring Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Glucose Monitoring Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Glucose Monitoring Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AstraZeneca Plc
• 2. B. Braun Melsungen AG
• 3. Bayer AG
• 4. Becton, Dickinson & Company
• 5. DexCom, Inc.
• 6. GE Healthcare
• 7. GlaxoSmithKline PLC
• 8. Johnson & Johnson Services, Inc.
• 9. Koninklijke Philips N.V.
• 10. Lupin Limited
• 11. Medtronic, Plc
• 12. Merck & Co., Inc.
• 13. Nova Biomedical Corporation
• 14. Novartis AG
• 15. Omron Corporation
• 16. ResMed Inc.